![Narjust Florez’s sessions at WCLC24 – Florez Lab](https://oncodaily.com/pub/uploads/2024/08/AD5KAsvS_400x400-e1723909307626.png)
Narjust Florez’s sessions at WCLC24 – Florez Lab
Florez Lab shared on X:
“Dr. Narjust Florez leads impactful sessions at WCLC24
Join her for the Early Career Investigator Workshop, Opening Plenary Session, Gender Equity in Thoracic Oncology Session.
Don’t miss these critical conversations on leadership and gender equity in oncology!”
Source: Florez Lab/X
More posts featuring Narjust Florez on oncodaily.com
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023